The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,801,702 in first-year total cost, median $900,851.
Most frequent study sections
- Special Emphasis Panel[ZAI1 JBS-A (S1)]2
Most frequent institutions
- HARVARD SCHOOL OF PUBLIC HEALTH1
- HENRY M. JACKSON FDN FOR THE ADV MIL/MED1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana1U01AI135940-01 | KURITZKES, DANIEL R.LICHTERFELD, MATHIASSHAPIRO, ROGER L | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $1,077,403 | ZAI1 |
| 2018 | Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines1U01AI135941-01 | ANANWORANICH, JINTANATPALMA, PAOLO | HENRY M. JACKSON FDN FOR THE ADV MIL/MED, MD | $724,299 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.